Siglec-1 (HSn 7D2) Antibody sc-53442 from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(2) Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltrationCancer immunology, immunotherapy : CIISeptember 1, 2022Kawaguchi S, Kawahara K, Fujiwara Y, Ohnishi K, Pan C, Yano H, Hirosue A, Nagata M, Hirayama M, Sakata J, et al.

(3) CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric CancerFrontiers in oncologyJanuary 1, 2021Kumamoto K, Tasaki T, Ohnishi K, Shibata M, Shimajiri S, Harada M, Komohara Y, Nakayama T.

(5) Loss of CD169(+) Subcapsular Macrophages during Metastatic Spread of Head and Neck Squamous Cell CarcinomaOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck SurgeryJuly 1, 2019Topf MC, Harshyne L, Tuluc M, Mardekian S, Vimawala S, Cognetti DM, Curry JM, Rodeck U, Luginbuhl A.

(6) Natural compounds that regulate lymph node sinus macrophages: Inducing an anti-tumor effect by regulating macrophage activationJournal of clinical and experimental hematopathology : JCEHJanuary 1, 2018Fujiwara Y, Saito Y, Shiota T, Cheng P, Ikeda T, Ohnishi K, Takeya M, Komohara Y.

(7) Immunophenotyping of Sheep Paraffin-Embedded Peripheral Lymph NodesFrontiers in immunologyJanuary 1, 2018Melzi E, Rocchi MS, Entrican G, Caporale M, Palmarini M.

(8) Reduced number of CD169⁺ macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patientsThe ProstateNovember 1, 2017Strömvall K, Sundkvist K, Ljungberg B, Halin Bergström S, Bergh A.human LNs were stained with a primary mouse monoclonal antibody against human CD169 (diluted 1:25, sc53442, Santa Cruz Biotechnology, Dallas, TX). The immunoreaction was detected using Vectastain ABC‐kit (Vector

(9) Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinomaCancer scienceJune 1, 2016Ohnishi K, Yamaguchi M, Erdenebaatar C, Saito F, Tashiro H, Katabuchi H, Takeya M, Komohara Y.

(10) PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In VivoPloS oneJanuary 1, 2016Aravantinou M, Frank I, Hallor M, Singer R, Tharinger H, Kenney J, Gettie A, Grasperge B, Blanchard J, Salazar A, et al.

(12) Immunohistochemical characterization of microglia in Nasu-Hakola disease brainsNeuropathology : official journal of the Japanese Society of NeuropathologyAugust 1, 2011Satoh J, Tabunoki H, Ishida T, Yagishita S, Jinnai K, Futamura N, Kobayashi M, Toyoshima I, Yoshioka T, Enomoto K, et al.

(13) Siglec-1 on monocytes is a potential risk marker for monitoring disease severity in coronary artery diseaseClinical biochemistryJuly 1, 2009Xiong YS, Zhou YH, Rong GH, Wu WL, Liang Y, Yang ZX, Geng HL, Zhong RQ.

(14) CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitisJCI insightJanuary 1, 0001"Itoh M, Suganami T, Kato H, Kanai S, Shirakawa I, Sakai T, Goto T, Asakawa M, Hidaka I, Sakugawa H, et al."

(16) Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169(+) macrophages by metastatic breast cancersEBioMedicineJanuary 1, 0001"Maeshima Y, Kataoka TR, Vandenbon A, Hirata M, Takeuchi Y, Suzuki Y, Fukui Y, Kawashima M, Takada M, Ibi Y, et al."breast cancer were obtained from Kyoto University Hospital (Kyoto, Japan). Immunohistochemistry for CD169 (sc-53442; clone HSn7D2; Santa Cruz Biotechnology, Santa Cruz, CA, RRID: AB_2254730, diluted 1:25) and CD68 (Roche/Ventana,

Siglec-1 (HSn 7D2) Antibody